While SIK2 is deemed to be a tumor promoter in most cases, in the context of GNAS mutated PDA, it is supposed to be a tumor suppressor, mainly because SIK2 plays different roles in different tissue and cells, similar to cAMP/PKA signaling. This evidence concerns the gene SIK2 and neoplasm.